Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer

Figure 9

The PPAR signature was an independent prognostic factor for BLCA in the TCGA set. (a) The univariate Cox analysis for evaluating the independent prognostic value of PPAR signature; (b) multivariate Cox analysis for evaluating the independent prognostic value of PPAR signature; (c) ROC curve analyses of the clinical characteristics and risk score.

(a)

(b)

(c)